{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:52:15Z","timestamp":1791355935002,"version":"4.3.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.clinthera.2005.07.009","type":"journal-article","created":{"date-parts":[[2005,9,10]],"date-time":"2005-09-10T07:39:42Z","timestamp":1126337982000},"page":"1064-1073","source":"Crossref","is-referenced-by-count":136,"title":["Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance"],"prefix":"10.1016","volume":"27","author":[{"given":"Robin P.","family":"Hertz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan N.","family":"Unger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Lustik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2005.07.009_bib1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2005.07.009_bib2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0168-8227(95)01064-K","article-title":"Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study","volume":"28","author":"Ohkubo","year":"1995","journal-title":"Diabetes Res Clin Pract"},{"issue":"Suppl2","key":"10.1016\/j.clinthera.2005.07.009_bib3","first-page":"B21","article-title":"Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients","volume":"23","author":"Shichiri","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2005.07.009_bib4","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1001\/jama.280.17.1490","article-title":"Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: A randomized, controlled, double-blind trial","volume":"280","author":"Testa","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2005.07.009_bib5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0168-8227(00)00122-4","article-title":"Cost-effectiveness of intensive insulin therapy for type 2 diabetes: A 10-year follow-up ofthe Kumamoto study","volume":"48","author":"Wake","year":"2000","journal-title":"Diabetes Res Clin Pract"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2005.07.009_bib6","first-page":"S28","article-title":"for the American Diabetes Association. Implications of the United Kingdom prospective diabetes study","volume":"26","author":"Genuth","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2005.07.009_bib7","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.2337\/diacare.24.8.1411","article-title":"Utilization of oral hypoglycemic agents in a drug-insured US population","volume":"24","author":"Boccuzzi","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2005.07.009_bib8","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0149-2918(01)80110-7","article-title":"Patient compliance and persistence with antihyperglycemic drug regimens: Evaluation of a Medicaid patient population with type 2 diabetes mellitus","volume":"23","author":"Dailey","year":"2001","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2005.07.009_bib9","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1046\/j.1464-5491.2002.00689.x","article-title":"Adherence to prescribed oral hypoglycaemic medication in a population of patients with type 2 diabetes: A retrospective cohort study","volume":"19","author":"Donnan","year":"2002","journal-title":"Diabet Med"},{"key":"10.1016\/j.clinthera.2005.07.009_bib10","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1177\/014572179902500406","article-title":"Sulfonylurea pharmacotherapy regimen adherence in a Medicaid population: Influence of age, gender, and race","volume":"25","author":"Sclar","year":"1999","journal-title":"Diabetes Educ"},{"key":"10.1016\/j.clinthera.2005.07.009_bib11","first-page":"491","article-title":"Persistence patterns with oral hypoglycemic agents in type 2 diabetes","volume":"9","author":"Stephens","year":"2002","journal-title":"J Clin Outcomes Manage"},{"key":"10.1016\/j.clinthera.2005.07.009_bib12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1345\/aph.18198","article-title":"Compliance with sulfonylureas in a health maintenance organization: A pharmacy record-based study","volume":"33","author":"Venturini","year":"1999","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinthera.2005.07.009_bib13","unstructured":"Centers for Disease Control and Prevention National Center for Health Statistics. Classifications of Diseases and Functioning & Disability. Available at: http:\/\/www.cdc.gov\/nchs\/about\/otheract\/icd9\/abticd9.htm\/\/. Accessed July 6, 2005."},{"key":"10.1016\/j.clinthera.2005.07.009_bib14","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/pds.1005","article-title":"Nonadherence as a predictor of antidiabetic drug therapy intensification (augmentation)","volume":"13","author":"Kogut","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"10.1016\/j.clinthera.2005.07.009_bib15","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1097\/00005650-199711000-00008","article-title":"Assessing compliance to antihypertensive medications using computer-basedpharmacy records","volume":"35","author":"Christensen","year":"1997","journal-title":"Med Care."},{"key":"10.1016\/j.clinthera.2005.07.009_bib16","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0895-7061(97)00056-3","article-title":"The effects of initial drug choice and comorbidityon antihypertensive therapy compliance: Results from a population-based study in the elderly","volume":"10","author":"Monane","year":"1997","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.clinthera.2005.07.009_bib17","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/0895-4356(91)90097-S","article-title":"Appropriate reductions in compliance among well-controlled hypertensive patients","volume":"44","author":"Steiner","year":"1991","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.clinthera.2005.07.009_bib18","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1097\/00004872-200409000-00029","article-title":"The association between compliance with antihypertensive drugs and modification of antihypertensive drug regimen","volume":"22","author":"Van Wijk","year":"2004","journal-title":"J Hypertens"},{"key":"10.1016\/j.clinthera.2005.07.009_bib19","series-title":"Modelling Survival Data in Medical Research","author":"Collett","year":"1994"},{"key":"10.1016\/j.clinthera.2005.07.009_bib20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1176\/appi.ajp.158.1.29","article-title":"The patient-provider relationship: Attachment theory and adherence to treatment for diabetes","volume":"158","author":"Ciechanowski","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2005.07.009_bib21","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0149-2918(99)80023-X","article-title":"Ten-year follow-up of antidiabetic drug use, nonadherence, and mortality in a defined population with type 2 diabetes mellitus","volume":"21","author":"Brown","year":"1999","journal-title":"Clin Ther."},{"key":"10.1016\/j.clinthera.2005.07.009_bib22","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1001\/archinte.161.8.1106","article-title":"Predictors of persistence of use of the novel antidiabetic agent acarbose","volume":"161","author":"Catalan","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2005.07.009_bib23","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1046\/j.1464-5491.2002.00749.x","article-title":"Adherence to oral hypoglycaemic agents prior to insulin therapy in type 2 diabetes","volume":"19","author":"Evans","year":"2002","journal-title":"Diabet Med."},{"key":"10.1016\/j.clinthera.2005.07.009_bib24","series-title":"Employer Health Benefits: 2004 Annual Survey","year":"2004"},{"key":"10.1016\/j.clinthera.2005.07.009_bib25","series-title":"The Stateof Healthcare Quality 2004 Industry Trends and Analysis","author":"National Committee for Quality Assurance (NCQA)","year":"2004"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291805001323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291805001323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T05:58:43Z","timestamp":1548136723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291805001323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0149291805001323"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2005.07.009","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}